https://fieldpulse.chat/news/acip-new-charter-vaccine-field-teams-coverage-credibility-2026 FieldPulse en 2026-06-25T22:04:43.206+00:00 ACIP's new charter raises fresh questions for vaccine field teams about credibility, coverage, and future recommendations https://fieldpulse.chat/news/cassidy-340b-bill-hospital-access-pricing-field-teams-2026 FieldPulse en 2026-06-25T22:04:39.717+00:00 Cassidy's 340B bill puts hospital access and pricing conversations back at the center for pharma field teams https://fieldpulse.chat/news/gilead-trodelvy-keytruda-first-line-tnbc-fda-approval-2026 FieldPulse en 2026-06-25T17:06:12.637+00:00 FDA approval gives Gilead and Merck a new first-line TNBC story with Trodelvy plus Keytruda https://fieldpulse.chat/news/pfizer-ibrance-double-positive-breast-cancer-fda-approval-2026 FieldPulse en 2026-06-25T17:06:12.637+00:00 Pfizer gets a new niche oncology message as Ibrance wins US approval in double-positive breast cancer https://fieldpulse.chat/news/eli-lilly-medicare-glp1-bridge-program-july-2026 FieldPulse en 2026-06-25T17:06:12.637+00:00 Eli Lilly's July 1 Medicare GLP-1 bridge launch could reset obesity access conversations https://fieldpulse.chat/news/gilead-trodelvy-first-line-tnbc-fda-approval-2026 FieldPulse en 2026-06-24T22:05:51.899+00:00 Gilead's Trodelvy wins broad first-line TNBC approval and changes the oncology field conversation https://fieldpulse.chat/news/florida-cvs-caremark-probe-field-access-2026 FieldPulse en 2026-06-24T22:05:51.899+00:00 Florida's CVS Caremark probe is early, but field and access teams should still watch it https://fieldpulse.chat/news/pfizer-ibrance-first-expansion-seven-years-2026 FieldPulse en 2026-06-24T22:05:51.899+00:00 Pfizer gives Ibrance its first breast cancer label expansion in seven years https://fieldpulse.chat/news/libtayo-nice-cervical-cancer-uk-access-win FieldPulse en 2026-06-24T17:04:55.622+00:00 Libtayo picks up a small but real UK access win in cervical cancer https://fieldpulse.chat/news/padcev-trodelvy-eu-oncology-approvals-field-impact FieldPulse en 2026-06-24T17:04:55.622+00:00 Padcev and Trodelvy notch new EU oncology wins that field teams will have to answer for https://fieldpulse.chat/news/pfizer-seagen-adc-setback-lung-cancer FieldPulse en 2026-06-24T11:34:58.965+00:00 Pfizer drug acquired in Seagen deal disappoints in lung cancer study https://fieldpulse.chat/news/merck-tl1a-tulisokibart-ibd-trial FieldPulse en 2026-06-24T11:34:58.965+00:00 MSD's TL1A drug tulisokibart delivers in pivotal IBD trial https://fieldpulse.chat/news/eli-lilly-340b-hospital-discount-dispute FieldPulse en 2026-06-24T11:34:58.965+00:00 Hospitals irate after Eli Lilly follows through on 340B ultimatum